You are here

molnupiravir

US plans shift of Merck COVID treatment to commercial market

Reuters

Thu, 10/5/23 - 10:16 am

Merck asks EMA to reevaluate rejected Covid-19 antiviral

Endpoints

Mon, 03/13/23 - 04:40 pm

Merck Covid antiviral pill did not cut hospitalization risk, study finds

Financial Times

Sun, 10/9/22 - 06:08 pm

US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf

Endpoints

Wed, 05/25/22 - 11:47 pm

ICER says Pfizer's Paxlovid, Merck's molnupiravir both cost effective, but their benefits are far from equal

Fierce Pharma

Tue, 05/10/22 - 10:50 am

Ridgeback Biotherapeutics

New Studies Support Benefit of Merck's Molnupiravir

BioSpace

Mon, 04/4/22 - 11:13 pm

Ridgeback Biotherapeutics

clinical trials

Merck antiviral used more than expected, data shows

Beckers Hospital Review

Mon, 03/14/22 - 11:35 pm

Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study

Forbes

Sun, 02/20/22 - 11:56 am

Ridgeback Biotherapeutics

FDA updates Merck's Covid-19 pill EUA and reaffirms it should only be used as a last resort

Endpoints

Fri, 02/18/22 - 10:25 am

Will a New FDA-Approved COVID Pill Propel This Healthcare Company's Stock?

Motley Fool

Sat, 02/5/22 - 12:04 pm

27 drugmakers to provide generic COVID drug to low-income countries

Pharmaforum

Thu, 01/20/22 - 11:29 pm

Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill

Reuters

Tue, 01/4/22 - 10:46 pm

France Rejects Merck's COVID-19 Pill: How Bad Is the News?

Motley Fool

Sun, 01/2/22 - 11:39 pm

FDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited

Stat

Thu, 12/23/21 - 12:03 pm

Merck’s Covid Pill Might Pose Risks for Pregnant Women

NY Times, NY

Mon, 12/13/21 - 11:52 pm

Why an FDA Panel Had Concerns About Merck's COVID-19 Pill

Motley Fool

Sat, 12/11/21 - 09:26 pm

FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19

Stat

Tue, 11/30/21 - 11:35 pm

Ridgeback Biotherapeutics

New Merck study results raise questions about its COVID-19 pill

BioPharma Dive

Fri, 11/26/21 - 08:55 pm

Covid antivirals could be pandemic game-changers. But Americans might struggle to access them

Stat

Tue, 11/23/21 - 09:41 am

Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?

Motley Fool

Fri, 11/19/21 - 10:52 am

Pages